期刊
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
卷 23, 期 2, 页码 194-203出版社
AMER SOC NEPHROLOGY
DOI: 10.1681/ASN.2011070680
关键词
-
资金
- US National Institutes of Health (NIH) [DK83375, DK83375S1, DK83912]
- European Union (EU)
- Austrian Vienna Science and Technology Fund
- Science Foundation Ireland [SFI PI 06/IN.1/B652, SFI SRC 09/SRC/B1794]
- Health Research Board of Ireland [HRA HSR/2010/63]
- United Kingdom Medical Research Council [G0700330, G0801235]
- Genzyme Renal Innovation Program
- Deutsche Forschungsgemeinschaft [Ku1063/5, KFO228, SFBTR57]
- EU consortium INTRICATE
- German National Academic Foundation
- NIH [DK73299, DK84077, DK8739]
- Genzyme Research in Progress Award
- Nephcure Foundation
- Sponsored Research Agreement with Regulus Therapeutics
- Medical Research Council [G0801235, G0700330] Funding Source: researchfish
- MRC [G0801235, G0700330] Funding Source: UKRI
The renal mononuclear phagocytic system, conventionally composed of macrophages (Mempty set) and dendritic cells (DCs), plays a central role in health and disease of the kidney. Overlapping definitions of renal DCs and M, stemming from historically separate research tracks and the lack of experimental tools to specifically study the roles of these cells in vivo, have generated confusion and controversy, however, regarding their immunologic function in the kidney. This brief review provides an appraisal of the current state of knowledge of the renal mononuclear phagocytic system interpreted from the perspective of immunologic function. Physical characteristics, ontogeny, and known functions of the main subsets of renal mononuclear phagocytes as they relate to homeostasis, surveillance against injury and infection, and immune-mediated inflammatory injury and repair within the kidney are described. Gaps and inconsistencies in current knowledge are used to create a roadmap of key questions to be answered in future research.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据